Transcription Factor Sp1 Is Involved in Expressional Regulation of Coxsackie and Adenovirus Receptor in Cancer Cells

被引:5
作者
Chung, Sun-Ku [1 ,2 ]
Kim, Joo-Young [1 ,3 ]
Lim, Joong-Yeon [1 ]
Park, Young Mi [1 ]
Hwang, Ha-Young [1 ]
Nam, Jae-Hwan [4 ]
Park, Sang Ick [1 ]
机构
[1] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Cheongwon Gun 363951, Chungcheongbuk, South Korea
[2] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA
[3] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea
[4] Catholic Univ Korea, Dept Biotechnol, Gyeonggi Do 420743, Bucheon, South Korea
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2011年
关键词
DEACETYLASE INHIBITOR FR901228; HUMAN BLADDER-CANCER; TRANSGENE EXPRESSION; MALIGNANT-CELLS; GROWTH; CAR; PROMOTER; BINDING;
D O I
10.1155/2011/636497
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Coxsackie and adenovirus receptor (CAR) was first known as a virus receptor. Recently, it is also known to have tumor suppressive activity such as inhibition of cell proliferation, migration, and invasion. It is important to understand how CAR expression can be regulated in cancers. Based on an existence of putative Sp1 binding site within CAR promoter, we investigated whether indeed Sp1 is involved in the regulation of CAR expression. We observed that deletion or mutation of Sp1 binding motif (-503/-498) prominently impaired the Sp1 binding affinity and activity of CAR promoter. Histone deacetylase inhibitor (TSA) treatment enhanced recruitment of Sp1 to the CAR promoter in ChIP assay. Meanwhile, Sp1 binding inhibitor suppressed the recruitment. Exogenous expression of wild-type Sp1 increased CAR expression in CAR-negative cells; meanwhile, dominant negative Sp1 decreased the CAR expression in CAR-positive cells. These results indicate that Sp1 is involved in regulation of CAR expression.
引用
收藏
页数:9
相关论文
共 17 条
  • [1] Anders M, 2003, CANCER RES, V63, P2088
  • [2] Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression
    Anders, M.
    Vieth, M.
    Roecken, C.
    Ebert, M.
    Pross, M.
    Gretschel, S.
    Schlag, P. M.
    Wiedenmann, B.
    Kemmner, W.
    Hoecker, M.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (02) : 352 - 359
  • [3] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323
  • [4] MITHRAMYCIN INHIBITS SP1 BINDING AND SELECTIVELY INHIBITS TRANSCRIPTIONAL ACTIVITY OF THE DIHYDROFOLATE-REDUCTASE GENE INVITRO AND INVIVO
    BLUME, SW
    SNYDER, RC
    RAY, R
    THOMAS, S
    KOLLER, CA
    MILLER, DM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1613 - 1621
  • [5] Goldsmith ME, 2003, CLIN CANCER RES, V9, P5394
  • [6] Sp1 is required for the early response of alpha 2(I) collagen to transforming growth factor-beta 1
    Greenwel, P
    Inagaki, Y
    Hu, W
    Walsh, M
    Ramirez, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) : 19738 - 19745
  • [7] The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
    Kim, M
    Sumerell, LA
    Belousova, N
    Lyons, GR
    Carey, DE
    Krasnykh, V
    Douglas, JT
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (09) : 1411 - 1416
  • [8] Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells
    Kitazono, M
    Rao, VK
    Robey, R
    Aikou, T
    Bates, S
    Fojo, T
    Goldsmith, ME
    [J]. BLOOD, 2002, 99 (06) : 2248 - 2251
  • [9] Kitazono M, 2001, CANCER RES, V61, P6328
  • [10] Induction of Id2 expression by cardiac transcription factors GATA4 and Nkx2.5
    Lim, Joong-Yeon
    Kim, Won Ho
    Kim, Joon
    Park, Sang Ick
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (01) : 182 - 194